Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease
Medical Sciences · 2024
DOI: 10.3390/medsci12040052 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medical Sciences, 2024. Verfasst von Juan Silva-Gallardo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital General Regional 25, Mexican Social Security Institute, Mexico City 09100, Mexico. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Nitric Oxide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: institutional funding.
Themen: COPD
Abstract (Originalsprache)
Chronic Obstructive Pulmonary Disease (COPD) is a disease characterized by local and systemic inflammation independently of the risk factor; during the exacerbations, such inflammation is accentuated and amplified. A practical inflammatory marker and one with an applicable predictive value in the follow-up has been sought. FeNO has shown an excellent performance in that respect within the context of asthma and has also been studied in tobacco-smoke COPD (COPD-TS). In Biomass-smoke COPD (COPD-BS), this, to our knowledge, has not been evaluated.
Objective
To measure FeNO levels in patients with COPD-BS and to compare these with those of patients with stable COPD-TS and in healthy controls.
Methods
Transversal, observational, descriptive, comparative, and analytical study. A total of 57 patients, including 23 with COPD-BS, 17 with COPD-TS, and 17 healthy control subjects. The measurement of FeNO was carried out on all of these by means of the on-line chemiluminescence technique; the values were expressed in parts per billion (ppb) for their analysis.
Results
It was observed that the FeNO values were similar between COPD-BS and COPD-TS and were significantly different between the healthy and stable COPD (both groups). No correlation was found between pulmonary function and symptoms with FeNO in any of the groups.
Conclusions
The level of FeNO in stable COPD is found to be increased in a similar manner in COPD-BS and COPD-TS, with a significant difference on comparing it with that of the healthy subjects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital General Regional 25, Mexican Social Security Institute, Mexico City 09100, Mexico.
- Respiratory Department, Médica Sur Hospital, Mexico City 14050, Mexico.
- Tobacco and COPD Research Department, Ismael Cosío Villegas National Institute of Respiratory Diseases, Mexico City 14080, Mexico.
- COPD and Bronchiectasis Clinic, Ismael Cosío Villegas National Institute of Respiratory Diseases, Mexico City 14080, Mexico.
ORCID-Profile: Robinson E Robles Hernández, Gustavo I Centeno-Saenz, Rafael J Hernández-Zenteno
Förderung
- institutional funding
Zitieren
APA
Silva-Gallardo, J., Sansores, R. H., Ramírez-Venegas, A., Robles Hernández, R. E., Centeno-Saenz, G. I., & Hernández-Zenteno, R. J. (2024). Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease. Medical Sciences. https://doi.org/10.3390/medsci12040052
Vancouver
Silva-Gallardo J, Sansores RH, Ramírez-Venegas A, Robles Hernández RE, Centeno-Saenz GI, Hernández-Zenteno RJ. Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease. Medical Sciences. 2024. doi:10.3390/medsci12040052
BibTeX
@article{SilvaGallardo2024,
author = {Silva-Gallardo, Juan and Sansores, Raúl H and Ramírez-Venegas, Alejandra and Robles Hernández, Robinson E and Centeno-Saenz, Gustavo I and Hernández-Zenteno, Rafael J},
title = {Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease},
journal = {Medical Sciences},
year = {2024},
doi = {10.3390/medsci12040052}
}
EUVIMED